Negative Affective States and Cognitive Impairments in Nicotine Dependence

┬╖ ┬╖
┬╖ Academic Press
рдИ-рдмреБрдХ
362
рдкреЗрдЬ
рдпреЛрдЧреНрдп
рд░реЗрдЯрд┐рдВрдЧ рдФрд░ рд╕рдореАрдХреНрд╖рд╛рдУрдВ рдХреА рдкреБрд╖реНрдЯрд┐ рдирд╣реАрдВ рд╣реБрдИ рд╣реИ ┬ардЬрд╝реНрдпрд╛рджрд╛ рдЬрд╛рдиреЗрдВ

рдЗрд╕ рдИ-рдмреБрдХ рдХреЗ рдмрд╛рд░реЗ рдореЗрдВ рдЬрд╛рдирдХрд╛рд░реА

Negative Affective States and Cognitive Impairments in Nicotine Dependence is the only book of its kind that addresses nicotine use and abuse in the context of negative reinforcement mechanisms. Written and edited by leading investigators in addiction, affective, genetic, and cognitive research, it provides researchers and advanced students with an overview of the clinical bases of these effects, allowing them to fully understand the various underlying dysfunctions that drive nicotine use in different individuals. In addition, this book examines animal models that researchers have utilized to investigate the biological bases of these dysfunctions. The combination of clinical and preclinical approaches to understanding nicotine dependence makes this book an invaluable resource for researchers and practitioners seeking to develop targeted treatments aimed at ameliorating symptoms of nicotine dependence, as well as identifying premorbid differences in affective or cognitive function. - Provides a unique perspective on nicotine dependence that emphasizes negative reinforcement rather than positive reinforcement - Examines psychiatric comorbidities and alleviation of withdrawal states as motivation for continued tobacco use - Includes both clinical and preclinical perspectives - Includes genetic and multi-neurotransmitter perspectives on nicotine use and withdrawal - Emphasizes heterogeneity of underlying reasons for smoking, the need for multiple animal models to understand this heterogeneity, and the expectation of heterogeneous responses to potential treatments, underscoring the need for personalized therapeutics

рд▓реЗрдЦрдХ рдХреЗ рдмрд╛рд░реЗ рдореЗрдВ

Dr. F. Scott Hall is an Assistant Professor of Pharmacology and Experimental Therapeutics in the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo. Dr. HallтАЩs research investigates the genetic and environmental determinants of susceptibility to addiction and related psychiatric disorders. After a B.A. from Harvard University (1987) and a Ph.D. from the University of Cambridge in 1994, Dr. Hall completed a postdoctoral fellowship at the National Institute on Alcoholism and Alcohol Abuse. Dr. Hall joined the Molecular Neurobiology Branch at the National Institute on Drug Abuse in 1999 where he led the behavioral genetics group until 2014. He has authored over a hundred scientific publications and is a fellow of the International Behavioral Neuroscience Society. Dr. Hall is recognized internationally as an expert in the genetic basis of addiction and the role that early social experience plays in shaping adult behavior and behavioral pathology.

Andre Der-Avakian, Ph.D., is an Assistant Research Scientist in the Department of Psychiatry at University of California, San Diego and an Adjunct Instructor in the Department of Psychological Sciences at University of San Diego. He received his Ph.D. in Neuroscience from University of Colorado, Boulder and completed a National Institute of Mental Health-sponsored postdoctoral fellowship at University of California, San Diego. Dr. Der-Avakian has published several research articles, reviews, and book chapters on the neurobiology of stress-induced disruption of normal reward processing in rats that may contribute to symptoms like anhedonia and motivational deficits in psychiatric disorders. His research, which is funded by grants from the National Institute of Mental Health and the National Institute on Drug Abuse, is focused on designing and implementing new translational behavioral and neurophysiological assessments of reward and cognitive processes in rats with high relevance to human psychiatric disorders like depression, schizophrenia, and drug addiction.

рдЗрд╕ рдИ-рдмреБрдХ рдХреЛ рд░реЗрдЯрд┐рдВрдЧ рджреЗрдВ

рд╣рдореЗрдВ рдЕрдкрдиреА рд░рд╛рдп рдмрддрд╛рдПрдВ.

рдкрдарди рдЬрд╛рдирдХрд╛рд░реА

рд╕реНрдорд╛рд░реНрдЯрдлрд╝реЛрди рдФрд░ рдЯреИрдмрд▓реЗрдЯ
Android рдФрд░ iPad/iPhone рдХреЗ рд▓рд┐рдП Google Play рдХрд┐рддрд╛рдмреЗрдВ рдРрдкреНрд▓рд┐рдХреЗрд╢рди рдЗрдВрд╕реНрдЯреЙрд▓ рдХрд░реЗрдВ. рдпрд╣ рдЖрдкрдХреЗ рдЦрд╛рддреЗ рдХреЗ рд╕рд╛рде рдЕрдкрдиреЗ рдЖрдк рд╕рд┐рдВрдХ рд╣реЛ рдЬрд╛рддрд╛ рд╣реИ рдФрд░ рдЖрдкрдХреЛ рдХрд╣реАрдВ рднреА рдСрдирд▓рд╛рдЗрди рдпрд╛ рдСрдлрд╝рд▓рд╛рдЗрди рдкрдврд╝рдиреЗ рдХреА рд╕реБрд╡рд┐рдзрд╛ рджреЗрддрд╛ рд╣реИ.
рд▓реИрдкрдЯреЙрдк рдФрд░ рдХрдВрдкреНрдпреВрдЯрд░
рдЖрдк рдЕрдкрдиреЗ рдХрдВрдкреНрдпреВрдЯрд░ рдХреЗ рд╡реЗрдм рдмреНрд░рд╛рдЙрдЬрд╝рд░ рдХрд╛ рдЙрдкрдпреЛрдЧ рдХрд░рдХреЗ Google Play рдкрд░ рдЦрд░реАрджреА рдЧрдИ рдСрдбрд┐рдпреЛ рдХрд┐рддрд╛рдмреЗрдВ рд╕реБрди рд╕рдХрддреЗ рд╣реИрдВ.
eReaders рдФрд░ рдЕрдиреНрдп рдбрд┐рд╡рд╛рдЗрд╕
Kobo рдИ-рд░реАрдбрд░ рдЬреИрд╕реА рдИ-рдЗрдВрдХ рдбрд┐рд╡рд╛рдЗрд╕реЛрдВ рдкрд░ рдХреБрдЫ рдкрдврд╝рдиреЗ рдХреЗ рд▓рд┐рдП, рдЖрдкрдХреЛ рдлрд╝рд╛рдЗрд▓ рдбрд╛рдЙрдирд▓реЛрдб рдХрд░рдХреЗ рдЙрд╕реЗ рдЕрдкрдиреЗ рдбрд┐рд╡рд╛рдЗрд╕ рдкрд░ рдЯреНрд░рд╛рдВрд╕рдлрд╝рд░ рдХрд░рдирд╛ рд╣реЛрдЧрд╛. рдИ-рд░реАрдбрд░ рдкрд░ рдХрд╛рдо рдХрд░рдиреЗ рд╡рд╛рд▓реА рдлрд╝рд╛рдЗрд▓реЛрдВ рдХреЛ рдИ-рд░реАрдбрд░ рдкрд░ рдЯреНрд░рд╛рдВрд╕рдлрд╝рд░ рдХрд░рдиреЗ рдХреЗ рд▓рд┐рдП, рд╕рд╣рд╛рдпрддрд╛ рдХреЗрдВрджреНрд░ рдХреЗ рдирд┐рд░реНрджреЗрд╢реЛрдВ рдХрд╛ рдкрд╛рд▓рди рдХрд░реЗрдВ.